Studies associated with ontology term
VT:1000783   'immune system trait'    
Navigate ontologies  


Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Ankra-Badu1 study archive Body, organ, fat pad weights, weight gain, litter size. QTL population both 2-10wks 2009
Auwerx1 cell signaling molecule detection
with high-fat diet 		INF-gamma, interleukins, monocyte chemoattractant, macrophage inflammatory protein, T cell RANTES, TNF-alpha. BXD w/par   (57) m 8-29 wks 2016
Auwerx2 organ weights
with high-fat diet 		Cecum, muscles, heart, heart-atria, kidney, liver, spleen, fat pads. inbred w/CC8 both 8-21 wks 2021
Benavides1 genotype assessment Gpr84 allele assessment. PCR, sequencing. inbred w/CC8   (58) both 6wks 2013
Benoist1 immune cell quantification Regulatory T cells (Treg), thymus, spleen. inbred   (33) m 5-6wks 2007
Boon1 body weight
with influenza A (H5N1) virus 		Influenza A (H5N1) virus (several doses) vs. baseline. inbred   (23) f 6-9wks 2011
Boon1 health assessment
with influenza A (H5N1) virus 		Survival rate, influenza A (H5N1) virus (several doses). Strain H5N1 susceptibility score. inbred   (23) f 6-9wks 2011
Bopp1 health assessment
with Plasmodium berghei 		Susceptibility, Plasmodium berghei (malaria). Parasitemia in blood and distribution in brain, spleen, lungs, liver. inbred   (31) both 8-12wks 2010
Brinkmeyer1 body weight
with Theiler's murine encephalomyelitis virus 		Body weight CC   (5) both 4wks 2017
Brinkmeyer1 health assessment
with Theiler's murine encephalomyelitis virus 		Clinical health assessment scores, TMEV infection. CC   (5) both 4wks 2017
Brinkmeyer1 RNA expression profiling
with Theiler's murine encephalomyelitis virus 		TMEV transcript abundance. CC   (5) both 4wks 2017
Brinkmeyer1 open field test
with Theiler's murine encephalomyelitis virus 		Locomotor activity, TMEV infection. CC   (5) both 4wks 2017
Brinkmeyer1 gait analysis
with Theiler's murine encephalomyelitis virus 		DigiGait analysis and footprint analysis, TMEV infection. CC   (5) both 4wks 2017
Brinkmeyer1 rotarod
with Theiler's murine encephalomyelitis virus 		Latency to fall from accelerating rotarod, TMEV infection. CC   (5) both 4wks 2017
Brockmann1 study archive Body, organ weights, litter size, abdominal fat, lipids, insulin, leptin. QTL population both 3-6wks 2009
CGDpheno1 complete blood count Hematology. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno3 complete blood count Hematology. CC diallel w/par   (62) both 8-16wks 2012
Chen1 immune cell quantification Natural killer T cells in peripheral blood, spleen, thymus. inbred   (38) both 8-10wks 2011
Chesler2 complete blood count Hematology. CC diallel w/par   (62) both 7-15wks 2011
Chesler3 complete blood count Hematology. CC pre w/par   (367) both 7-15wks 2011
Chesler3 organ weights Heart, brain, kidney, spleen, gonadal fat pads, testicle weights. CC pre w/par   (367) both 7-15wks 2011
Cheverud1 organ weights
with high-fat diet 		Heart, liver, kidney, spleen weights after high-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Clemens1 study archive
with ultraviolet light 		Immunosuppression of contact hypersensitivity after ultraviolet light exposure QTL population both 9-30wks 2000
Collins1 complete blood count Hematology. CC pre w/par   (139) m 10-14wks 2012
Cowell1 health assessment
with Staphylococcus aureus 		Survival rate, Staphylococcus aureus. inbred   (13) f 8wks 2012
Cowell1 hormone quantification
with Staphylococcus aureus 		Interleukin 6 levels (serum) after infection with Staphylococcus aureus. Kidney and peritoneal fluid. inbred   (13) f 8wks 2012
Cowell1 in vitro assay
with Staphylococcus aureus 		Bacterial load after infection with Staphylococcus aureus. Kidney and peritoneal fluid. In vitro assay. inbred   (13) f 8wks 2012
Deschepper1 organ weights Heart, kidney, thymus, adrena weights. inbred   (13) both 10wks 2004
Dietrich1 in vitro assay
with Bacillus anthracis lethal toxin 		Bacillus anthracis lethal toxin (anthrax) susceptibility. inbred   (50) f 6-8wks* 1998
Donahue5 immune cell quantification White blood cell and immune cell differentials. B6.A consomic w/par   (22) both 7wks 2011
Donahue6 immune cell quantification White blood cell and immune cell differentials. B6.PWD consomic w/par   (28) both 7wks 2011
Donahue7 immunoglobulin quantification Immunoglobulin concentrations (plasma). B6.A consomic w/par   (22) both 9wks 2012
Donahue8 immunoglobulin quantification Immunoglobulin concentrations (plasma). B6.PWD consomic w/par   (28) both 9wks 2011
Eumorphia1 complete blood count Hematology. inbred   (8) both 12wks 2007
Eumorphia7 immunoglobulin quantification Immunoglobulin concentrations (serum). inbred   (6) both 9-12wks 2008
Farmer1 study archive Colitis susceptibility, severity. Colon histopathology, body and spleen weight. QTL population both 6wks 2001
Ferris1 health assessment
with influenza A (H1N1) virus 		Clinical health assessment score and strain susceptibility index 4 days after infection with influenza A (H1N1) virus. CC pre w/par   (163) f 8-16wks 2012
Ferris1 in vitro assay
with influenza A (H1N1) virus 		Viral replication log titer 4 days after infection with influenza A (H1N1) virus. In vitro. CC pre w/par   (163) f 8-16wks 2012
Ferris1 histopathology
with influenza A (H1N1) virus 		Lungs and airway 4 days after infection with influenza A (H1N1) virus. CC pre w/par   (163) f 8-16wks 2012
Gatti2 study archive Whole blood neutrophil count and white cell count. DO population both 10-12wks 2014
GMC15 complete blood count Hematology. inbred w/CC8   (8) both 20-21wks 2020
GMC20 immunoglobulin quantification Immunoglobulins (plasma). inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC21 organ weights Heart, liver, spleen weights. inbred w/CC8   (8) both 20-21wks 2020
Graham1 body weight
with West Nile virus 		Body weight CC RIX   (5) m 8-10wks 2015
Graham1 health assessment
with West Nile virus 		Clinical score. CC RIX   (5) m 8-10wks 2015
Graham1 immune cell quantification
with West Nile virus 		T cell populations in brain and spleen. CC RIX   (5) m 8-10wks 2015
Graham1 RNA expression profiling
with West Nile virus 		Viral load and expression of Ifnb1 and Ifit1 in brain, kidney and spleen. CC RIX   (5) m 8-10wks 2015
Graham2 colony observation
with SARS-CoV 		Body weight loss and mortality. CC RIX   (117) f 8-10wks 2021
Graham2 in vitro assay
with SARS-CoV 		Lung viral load (log10). CC RIX   (117) f 8-10wks 2021
Graham3 immune cell quantification Baseline splenic T cell subsets. CC RIX   (104) m 8-10wks 2021
Graubert1 complete blood count
with ENU 		Hematology. inbred   (20) both 9wks; 12-64wks 2006
Gros1 in vitro assay
with Candida albicans 		Susceptibility to infection with Candida albicans. inbred   (36) f 8-12wks 2011
Gros2 health assessment
with Plasmodium chabaudi 		Survival score and susceptibility, Plasmodium chabaudi. inbred   (25) both 8-10wks 2012
Gros2 microscopy
with Plasmodium chabaudi 		Percent of Plasmodium chabaudi-infected erythrocytes in blood. inbred   (25) both 8-10wks 2012
Hackstein1 immune cell quantification Respiratory dendritic cell subsets and lymphocyte populations. inbred   (5) m 7-11wks 2012
Harrill1 organ weights
with isoniazid 		Body, liver, kidney weights. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Haston1 bronchoalveolar lavage assessment
with radiation 		Bronchoalveolar cell differential after exposure to radiation (18 Gy). inbred   (26) both 15-36wks 2012
Haston1 histopathology
with radiation 		Post exposure to radiation. inbred   (26) both 15-36wks 2012
Hillebrands1 histopathology Kidney pathology at 20mo. inbred   (23) both 87wks 2014
HMDPpheno5 complete blood count Hematology. HMDP   (83) m 16wks 2013
Jax2 MHC haplotype tissue typing Major histocompatibility complex (MHC) H2 haplotype. inbred   (56) both 2000
JaxCC1 complete blood count Hematology. CC   (18) both various 2018
JaxKOMP-EAP organ weights Heart weight. Raw and normalized to body weight. KOMP both 8-18wks 2021
JaxKOMP-EAP complete blood count Hematology parameters. KOMP both 8-18wks 2021
JaxKOMP-LAP complete blood count Hematology parameters. KOMP both 66-81wks 2021
Jaxpheno2 organ weights Brain, heart, kidney, liver, spleen weights. inbred   (11) both 8, 16 wks 2006
Jaxpheno4 complete blood count Hematology. inbred   (11) both 8, 16 wks 2006
Jaxpheno6 immune cell quantification White blood cell and immune cell differentials. inbred   (11) both 8, 16 wks 2006
Justice2 complete blood count Hematology. inbred   (16) both 12-16wks 2002
Lake1 complete blood count Hematology. B6.A consomic w/par   (23) both 7-11wks 2005
Leiter2 study archive Type 1 diabetes development study. QTL population f 14-40wks 2009
Lesage1 immune cell quantification Immunological cell variation. CC w/par   (76) both 5-8wks 2018
Lesage2 immune cell quantification total number of splenocytes, number of B cells in spleen, and percentage of splenocytes that are B cells CC w/par   (76) both 5-8wks 2024
Mahler1 study archive Colitis susceptibility. Colon histopathology, spleen weight. QTL population both 6wks 2002
Mathews1 study archive Type 1 diabetes resistance. QTL population f 8-40wks 2003
Mills1 apoptosis assessment Aging study, 6mo, 12mo, 20mo. inbred   (30) both 26, 52, 87 wks 2008
Mrug1 study archive Kidney morphology. QTL population both 1-2wks 2005
Peters1 complete blood count Hematology. inbred w/CC7   (43) both 10wks 2001
Peters2 complete blood count Hematology. AXB BXA   (28) both 11wks 2004
Peters4 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (30) both 26, 52, 78, 104 wks 2007
Petkova1 immune cell quantification Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2007
Powell1 in vitro assay
with Neisseria musculi 		Bacterial load after inoculation with Neisseria musculi. Oral cavity. inbred w/CC8   (8) both 8-16wks 2018
Reed2 organ weights Brain, heart, kidney, liver, pancreas, spleen weights. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reifsnyder2 study archive Type 1 diabetes onset. QTL population f 12-40wks 2005
RIKEN-EAD1 complete blood count Hematology. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD2 complete blood count Hematology. wild-derived RBRC   (33) both 8, 12 wks 2008
Rodriguez1 study archive Spleen, liver murine cytomegalovirus study. QTL population both 8-12wks 2009
Schoonjans1 organ weights
with high-fat diet 		Liver, spleen, kidney, fat pads, muscles, cecum. BXD w/par   (36) m 8-29 wks 2022
Schughart1 health assessment
with influenza A (H1N1) virus 		Strain susceptibility score, influenza A (H1N1) virus. inbred   (9) both 10-12wks 2009
Schughart2 health assessment
with influenza A (H1N1) virus 		Survival rate, susceptibility, influenza A (H1N1) virus. BXD w/par   (56) f 9-18wks 2012
Schughart3 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. inbred w/CC8   (8) both 7-13wks 2013
Schughart3 health assessment
with influenza A (H3N2) virus 		Survival rate, susceptibility, influenza A (H3N2) virus (several doses). inbred w/CC8   (8) both 7-13wks 2013
Schughart4 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schughart4 complete blood count
with influenza A (H3N2) virus 		White blood cell count and differentials. Influenza A (H3N2) virus vs. controls. inbred w/CC8   (8) f 8-12wks 2016
Schughart4 in vitro assay
with influenza A (H3N2) virus 		Viral load in lungs after infection with influenza A (H3N2) virus. inbred w/CC8   (8) f 8-12wks 2016
Schughart5 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schwartz2 bronchoalveolar lavage assessment
with ovalbumin 		Lung inflammatory changes. Ovalbumin vs. control. inbred   (8) m 6-8wks 2001
Sundberg2 study archive Alopecia areata autoimmune disease susceptibility. QTL population both 52wks 2003
Svenson3 complete blood count Hematology. B6.PWD consomic w/par   (28) both 9wks 2006
Williams1 immune cell quantification CD4 T cells, various populations. inbred   (5) f 8wks 2012
Wiltshire4 immune cell quantification
with BEZ235, doxorubicin, idarubicin, selumetinib 		In vitro study of 4 cancer chemotherapies (BEZ235, doxorubicin, idarubicin, selumetinib) vs. control. Effect on immune cells. Normalized data. inbred w/CC7   (36) m 10wks 2015